Responses
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – other biologic treatment
THU0099 Monitoring of abatacept in rheumatoid arthritis patients with previous failure to biotherapies suggests that CTLA-4/CD3E and/or CD28/CTLA-4 MRNA ratio may predict response to treatment at 3 months
Compose a Response to This Article
Other responses
No responses have been published for this article.